Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      ACTIVE_NOT_RECRUITING
      Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
      Description

      This phase II trial studies how well pembrolizumab works in treating patients with rare tumors that cannot be removed by surgery or have spread to other parts of the body. Monoclonal antibodies, such as pembrolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor growth.

      Conditions
      Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland PheochromocytomaMetastatic Kidney Medullary CarcinomaMetastatic Malignant Germ Cell TumorMetastatic Malignant Solid NeoplasmMetastatic ParagangliomaMetastatic Penile CarcinomaMetastatic Skin Squamous Cell CarcinomaSmall Cell CarcinomaStage III Adrenal Cortex Carcinoma AJCC v7Stage IV Adrenal Cortex Carcinoma AJCC v7Stage IV Penile Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7Unresectable Adrenal Gland PheochromocytomaUnresectable ParagangliomaUnresectable Skin Squamous Cell CarcinomaUnresectable Solid NeoplasmVascular Neoplasm
      Talk to us